Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer’s Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis
- 4 November 2016
- journal article
- review article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 54 (9) , 7297-7311
Abstract
Alzheimer’s disease (AD) is becoming a growing global problem, and there is an urgent need to identify reliable blood biomarkers of the risk and progression of this condition. A potential candidate is the brain-derived neurotrophic factor (BDNF), which modulates major trophic effects in the brain. However, findings are apparently inconsistent regarding peripheral blood BDNF levels in AD patients vs. healthy people. We thus performed a systematic review and meta-analysis of the studies that have examined peripheral BDNF levels in patients with AD or mild cognitive impairment (MCI) and healthy controls. We searched articles through PubMed, EMBASE, and hand searching. Over a total pool of 2061 potential articles, 26 met all inclusion criteria (including a total of 1584 AD patients, 556 MCI patients, and 1294 controls). A meta-analysis of BDNF levels between early AD and controls showed statistically significantly higher levels (SMD [95 % CI]: 0.72 [0.31, 1.13]) with no heterogeneity. AD patients with a low (P < 0.0001, I2 = 85.8 %). There were no differences in blood BDNF levels among AD or MCI patients vs. controls by subgroup analyses according to age, sex, and drug use. In conclusion, this meta-analysis shows that peripheral blood BDNF levels seem to be increased in early AD and decreased in AD patients with low MMSE scores respectively compared with their age- and sex-matched healthy referents. At present, however, this could not be concluded from individual studies.Keywords
This publication has 81 references indexed in Scilit:
- Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological DiseasesBioMed Research International, 2013
- Brain-Derived Neurotrophic Factor and Neuropsychiatric DisordersPharmacological Reviews, 2012
- Epidemiology of Alzheimer diseaseNature Reviews Neurology, 2011
- Serum Brain-Derived Neurotrophic Factor Levels Are Specifically Associated with Memory Performance among Alzheimer’s Disease CasesDementia and Geriatric Cognitive Disorders, 2010
- Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatmentMolecular Psychiatry, 2010
- Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin miceProceedings of the National Academy of Sciences, 2009
- Population genetic study of the brain-derived neurotrophic factor (BDNF) geneMolecular Psychiatry, 2009
- How to Select, Calculate, and Interpret Effect SizesJournal of Pediatric Psychology, 2009
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003